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Abstract
BACKGROUND: In response to the growing epidemic of prediabetes and diabetes (type 2), the
State of Connecticut passed Public Act 19-72 “An Act Concerning Dental Practitioners”
effective July 1, 2019 allowing licensed dentists to administer an in-office blood screening test to
consenting patients identified as having an increased risk for diabetes. The intent of this law is to
expand the venues to screen, identify and inform those at-risk for disease.
METHODS: An anonymous online cross-sectional pilot study was conducted utilizing
membership of major statewide dental societies to recruit licensed practicing dentists in the state
of Connecticut. Participants completed a 17-item survey that assessed knowledge of the law and
the Prediabetes Risk Test, perceptions pertaining to prediabetes and willingness to administer the
in-office blood test.
RESULTS: Participants were 23 licensed dentists in Connecticut. The majority are males (n=16,
69.6%) with 20 years plus of experience specializing in a private or group General Dentistry
practice. Awareness of the law is low (22%), yet the majority agree it is important to collaborate
with primary care providers to prevent disease (90%), screen patients identified at-risk for
prediabetes (85%) and inform patients of a prediabetic condition (85%).
CONCLUSION: Lack of awareness of the new law supports the need for increased
communication and educational efforts to the dental community. Additional research is
recommended to explore factors related to incorporating testing in order to better frame
messaging to this population and ensure adoption of a new point of care to combat the diabetes
epidemic.
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Foundational Competencies
Select quantitative and qualitative data collection
methods appropriate for a given public health context

Analyze quantitative and qualitative data using
biostatistics, informatics, computer-based
programming and software, as appropriate

Original anonymous 17 question quantitative survey created
utilizing Qualtrics. Developed multiple choice and 5-point
Likert scale questions found in the literature as well as novel
items.
Utilized IBM SPSS 26 software to analyze quantitative data
collected. Performed frequency analysis and chi-square tests
to analyze associations.

Interpret results of data analysis for public health
research, policy or practice

Summarized variables using descriptive statistics and
interpreted data for associations.

Design a population-based policy, program, project or
intervention

Data collected could lead to further advocacy to promote
awareness of new law and promote the incorporation of
Prediabetes Risk Test to increase awareness among patient
population
Proposed increased collaboration between dental community
and primary care providers to increase identification of
prediabetes among at-risk patients and improve overall
health of patient
Developed a Systems thinking map to identify all
stakeholders involved in this public health issue of the
increasing epidemic of prediabetes

Propose strategies to identify stakeholders and build
coalitions and partnerships for influencing public
health outcomes
Apply systems thinking tools to a public health issue

Concentration Competencies
Demonstrate use of Systems Thinking (ST) in
promoting effective public health programs and
policies.

Project summary:
To address the fact that one in three adults in the
United States is prediabetic and 90% are unaware of
their condition, with input from my committee as well
as well as from members of the dental community, an
anonymous survey was developed. The primary goal of
the survey was to examine knowledge of a new law
passed in Connecticut in July 2019 pertaining to inoffice testing of HbA1c in patients and willingness to
administer the test. We also examined knowledge of
the “7 Question Prediabetes Risk Test” and the
likelihood of incorporating this screening tool into their
patient information forms. Through contacts I made at
the Connecticut State Dental Association, Connecticut
Oral Health Initiative and the Hartford Dental Society,
the survey was distributed to licensed practicing
dentists in Connecticut utilizing their member lists and
social media platforms. I also attended a meeting held
by the Hartford Dental Society to speak about the
project. Further research is needed in this area and
additional distribution channels will be explored to
increase participation among the dental community.

Developed a Systems thinking map to identify a process by
which this at-risk population of dental patients could be
identified. The map also shows the importance of
collaboration between the dental community and the medical
community and how all stakeholders are involved in this
public health issue.
The following stakeholders were involved in the
development and distribution of the survey:
• Connecticut State Dental Association (CSDA)
• Hartford Dental Society
• Connecticut Oral Health Initiative (COHI)
• Licensed practicing dentists
The following stakeholders would be potential consumers of
the findings:
• Licensed practicing dentists in CT
• CSDA and Component Societies
• COHI
• CT Department of Public Health
• CT Legislature including PH committee
• American Diabetes Association
• American Dental Association
• Local Health Departments
• American Heart Association
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Systems Thinking Framework

Access to care

Systems Thinking Approach to Identifying Prediabetes in the Dental Setting

Indirect Stakeholder
Department of Public Health
Improving health of residents of Connecticut

•
•
•
•

Systems approach to collaborative care
Patient starts and follows up with dentist on the recommended schedule
for oral care and glucose measurements if necessary.

•

Patient

•

Primary Care Provider (PCP)
With patient consent, PCP confirms prediabetic or
diabetic diagnosis and provides counseling
appropriate to the condition.
Primary care provider collaborates with dental
community providers to address overall health of the
patient.
Indirect stakeholder
Counselor
Lifestyle interventions
Healthier eating/Exercise options

Front office staff

•
•

Insurance/Billing codes/Reimbursement/Out of pockets costs

Indirect Stakeholder
Insurance companies
Insurance coverage/billing
codes/reimbursement/out of pocket costs
• Coverage for this procedure is inconsistent
• Billing code D0411 HbA1c in-office point of
service testing was effective January 1, 2018
• If test is not covered, patients may not pay
out of pocket for the procedure

•

Indirect Stakeholders
American Dental Association/CT State Dental
Association/American Diabetes Association/American Heart
Association
•

Patient
Post-office visit with dentist and PCP
Patient identified at-risk for prediabetes or diabetes
from Prediabetes Risk Test or in-office HbA1c test
Patient referred to PCP for follow up
Patient is confirmed as prediabetic, diabetic or
neither.
Patient is given informational materials on lifestyle
changes to improve health outcomes.

Primary Care
Provider (PCP)

Dental
Hygienist/Dentist

Collaboration among all stakeholders is
the key to increasing awareness of
prediabetes among at-risk individuals.
With increased awareness, the option
to improve health becomes a choice.

•
•

84 million adults in the United States are identified as prediabetic and
90% are unaware of their condition
A systems thinking approach is critical to understanding why this level
of awareness is so low, incorporating diagnostic tools into at-risk
patient visits, collaborating between medical professions which in
turn will improve the percentage of Americans that are aware of this
chronic life altering condition before it develops into type 2 diabetes.

Education level – knowledge of
importance of oral health

Patient Pre-office visit with dentist
Patient is unaware of glucose levels and risk for
prediabetes, diabetes or periodontitis
Front office staff/Patient appointment
Patient arrives and receives Prediabetes Risk Test
with other information forms
Patient completes Prediabetes Risk Test to determine
risk score.
Front office determines insurance eligibility for
patient to receive in-office HbA1c test to measure
glucose level.

Indirect Stakeholder
Lawmakers/Policy Makers
Passing and advocating legislation
“An Act Concerning Dental Practitioners”

•
•

•
•
•

Indirect Stakeholder
Medical Equipment and
Testing Providers
Equipment needed to
administer HbA1c test

Dental Hygienist/Dentist
Dental hygienist consults with patient regarding Risk
Test Score. This is within their scope of work.
If patient is determined at-risk for prediabetes or
diabetes or complications from planned oral care
treatment, dental hygienist recommends in-office
HbA1c test to measure glucose level.
With patient consent, under current law in
Connecticut, dentist administers in-office finger-stick
glucose test to measure HbA1c
HbA1c measurement determines referral to PCP.
>=5.7% = referral to PCP
Dentist and dental hygienist consult patient on the
impact of glucose levels on oral health, specifically
periodontitis.
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Introduction
A. Research Significance
Prediabetes is an epidemic that affects 84.1 million adults in the United States. This is
not only a public health problem in the United States, but prevalence estimates of prediabetes
worldwide are projected to be over 470 million people by 2030 (Tabak, Herder, Rathmann,
Brunner, & Kivimaki, 2012). Prediabetes is a serious preventable health condition in which an
individual has blood sugar levels that are higher than normal but not yet high enough to be
diagnosed as diabetes (Centers for Disease Control and Prevention, n.d.). It has been estimated
that one in three adults in the United States has prediabetes, yet reports have shown that up to
90% are unaware they have this condition (National Diabetes Statistics Report, 2017). This
undiagnosed population has a risk four to twelve time greater than those with normal glucose
tolerance of developing type 2 diabetes (Albright & Gregg, 2013) and also has an increased risk
of cardiovascular disease, stroke and all-cause mortality (Tseng, et al., 2019; Zand, Ibrahim, &
Patham, 2018). Studies show that for those individuals diagnosed with prediabetes that make
lifestyle changes, they can lower their risk of developing type 2 diabetes by as much as 71
percent depending on their age (Centers for Disease Control and Prevention, n.d.).
The annual incidence of type 2 diabetes is 5%-10% in people with prediabetes compared
to approximately 1% in the population with normal glucose tolerance (Albright & Gregg, 2013).
If prediabetes is left undiagnosed and therefore untreated, potentially 30% of people will develop
type 2 diabetes within five years (Estrich, Araujo, & Lipman, 2019). The implications of
developing type 2 diabetes are staggering and include vision loss, amputation, kidney issues,
disability and death (Albright & Gregg, 2013). Not only do these conditions present a substantial

1

burden to the individual, but also annual costs associated with diabetes were estimated to be
$327 billion in the United States (Estrich, Araujo, & Lipman, 2019).
In order to treat prediabetes, which is a preventable, reversible condition, this
undiagnosed population must first be properly identified and made aware they are prediabetic.
There is an opportunity to reach a large number of individuals that visit a dentist but do not visit
a medical doctor (Estrich, Araujo, & Lipman, 2019). This distinction is important, as diabetes is
also a major risk factor for periodontitis with the risk being three times that among non-diabetic
individuals (Preshaw, et al., 2012). Periodontitis is a chronic inflammatory condition that if not
controlled can ultimately lead to tooth loss. There is evidence of a bi-directional relationship
between diabetes increasing the risk for periodontitis and those with periodontitis controlling
their blood sugar (Preshaw, et al., 2012).
Given the relationship between diabetes and periodontitis coupled with the national goals
to reduce the prevalence of diabetes, Connecticut and other states have passed legislation to
enable dentists to screen for prediabetes and diabetes to enlarge the possibility of identifying
people at risk. Specifically in Connecticut, Public Act No. 19-72 AN ACT CONCERNING
DENTAL PRACTITIONERS effective July 1, 2019 allows licensed practicing dentists “during
an office visit or prior to a procedure and with the patient’s consent to administer an in-office
point-of-service test to the patient to measure the patient’s HbA1c percentage utilizing a fingerstick measurement tool if such patient is at an increased risk of diabetes and does not have a
previous diagnosis of diabetes” (An Act Concerning Dental Practitioners, 2019). Given the
recency of this legislation, it remains unknown the degree to which dentists are willing to
incorporate this testing during normal office visits, and what factors might drive their decisions.
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B. Definitions and scope
Prediabetes is an epidemic of global proportions. In 2015, an estimated 33.9% of adults
in the United States aged 18 years and older had prediabetes identified using plasma fasting
glucose (PFG) or glycohemoglobin (HbA1c) levels. Prediabetes affects nearly half of adults age
65 years or older (48.3%) and more men (36.6%) than women (29.3%). Among racial groups,
the prevalence of prediabetes was highest among the Asian, non-Hispanic (35.7%) and the
Black, non-Hispanic (36.3%) populations. Among adults aged 18 years and older, only 11.6%
reported awareness of prediabetes which was identified from the Diabetes Questionnaire in the
2015-2016 National Health and Nutrition Examination Survey (NHANES 2015-2016), “{Have
you/Has SP} ever been told by a doctor or other health professional that {you have/SP has} any
of the following: prediabetes, impaired fasting glucose, impaired glucose tolerance, borderline
diabetes or that {your/her/his} blood sugar is higher than normal but not high enough to be
called diabetes or sugar diabetes?”
The lowest levels of awareness of this preventable disease were identified in adults ages
18 to 44 (8.2%), men (9.4%) and Hispanics (7.5%) (National Diabetes Statistics Report, 2017).
If left undiagnosed and untreated, 30% of this population will develop type 2 diabetes within five
years which overall is the seventh leading cause of death in the United States (Estrich, Araujo, &
Lipman, 2019) (Heron, 2019).
Prediabetes can be identified from bloodwork in which there is an impaired fasting
plasma fasting glucose (FPG) value or an elevated HbA1c value not high enough to be diagnosed
as type 2 diabetes. A prediabetic impaired fasting glucose is defined by the American Diabetes
Association (ADA) as a range between 100mg/dL and 125mg/dL. A prediabetic HbA1c level is
defined by the ADA as a lab value ranging between 5.7% and 6.4% (Zand, Ibrahim, & Patham,
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2018). An oral glucose tolerance test (OGTT) can also be a tool to identify prediabetes but is not
commonly used in the general population because it is expensive and impractical to use within
the routine setting of a doctor’s visit (Fagg & Valabhji, 2019). Examining laboratory results of
fasting plasma glucose values from NHANES 2005-2006 compared to results from NHANES
2015-2016 to identify prediabetes in the survey population measured, prevalence has more than
doubled from 8.8% to 18.2% in that ten-year period. Laboratory results of HbA1c values from
NHANES 2005-2006 compared to results from NHANES 2015-2016 prevalence has increased
from 9.1% to 24.2% in that ten-year period. It can be inferred that because almost 90% of
American adults are unaware of their prediabetic condition, the prevalence of diabetes identified
using these same NHANES datasets and the definition set by the ADA of a fasting plasma
glucose value greater than 125mg/dL has also increased from 3.3% to 5.8%. In addition, those
with an HbA1c value greater than 6.4%, defined as diabetes by the ADA has also increased from
6.1% (NHANES 2005-2006) to 10.4% (NHANES, 2015-2016).
Prediabetes is typically asymptomatic. Therefore, it is unlikely to be detected until
serious health problems arise, making earlier diagnosis a healthcare priority. It is important to
screen for prediabetes if the following risk factors are present: being overweight, age 40 years or
older, having a family member with type 2 diabetes, low physical activity (<3 times/week),
females that have had gestational diabetes or a baby that weighed 9 pounds or more or having
polycystic ovary syndrome. African Americans, Hispanic/Latino Americans, American Indians
and some Asian Americans may have a higher risk as well (What is Prediabetes?, 2019). Type 2
diabetes is preventable and can be delayed through methods such as healthy eating, weight loss
and increasing physical activity (Gruss, et al., 2019).
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Current knowledge/Gaps in Literature
A common theme in the literature addresses the growing epidemic of diabetes concurrent
with a lack of knowledge of prediabetes. Several factors contribute to this increase in prevalence
starting with approximately 90% of American adults lacking awareness of this disease as a result
of under diagnosis (Tseng et al., 2019). The role of a healthcare professional such as a primary
care provider or dental provider is key to identifying the need for an initial screening using
known risk factors and a concurrent diagnosis of prediabetes if identified through confirmatory
laboratory values. By examining the existing knowledge within the dental community, the results
may provide additional evidence and support for further research into why 90% of the population
identified as prediabetic remains unaware of their condition.
C. Prior Research
In a study performed by Tseng et al. (2019), there are significant gaps in knowledge of
prediabetes by primary care physicians (PCP) as well as an underutilization of behavioral
programs focused on weight loss and lifestyle modifications. Only 38% of PCP identified Latino
ethnicity as a risk factor and only 27% identified Asian race that would prompt prediabetes
screening. As mentioned earlier, these groups are at higher risk for prediabetes and should
prompt screening if appropriate, especially if other risk factors are present. Awareness of
prediabetes is 7.5% in the Hispanic population and 9% in the Asian population (National
Diabetes Statistics Report, 2017) which could be attributed to these lower levels of identification
among PCP’s (Tseng et al., 2019). Physician knowledge of the correct laboratory criteria for
diagnosing prediabetes as defined by ADA was 42% for fasting glucose and 31% for HbA1c
which could also be a factor in underdiagnosing this condition. Physician knowledge of
recommendations for the management of prediabetes was relatively low with 25% answering
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“Do not know” and only 8% reporting the correct goal of a minimum of 7% for weight loss
recommended by the ADA. Knowledge of recommended activity levels used for prediabetes
management was also low with 13% reporting “Do not know” and 41% reporting the correct
level defined by the ADA of 150 minutes per week (Tseng et al., 2019).
Although lifestyle modification programs have proven to be very effective with evidence
that shows a 40% to 70% relative-risk reduction in preventing the development of type 2
diabetes from a prediabetic state (Tabak, Herder, Rathmann, Brunner, & Kivimaki, 2012), only
36% of primary care physicians surveyed reported referring patients to a diabetes prevention
lifestyle program (Tseng et al., 2019). PCP’s lack of knowledge of risk factors, laboratory
criteria and effective evidence-based prediabetes management recommendations likely
contributes to the increasing prevalence of type 2 diabetes. This is compounded by delayed
diagnosis by healthcare professionals even after an initial elevated HbA1c value has been
documented.
In a study by Gopalan et al., (2018), the prevalence of undiagnosed Type 2 diabetes one
year following an elevated HbA1c was examined using electronic health records from a cohort of
Kaiser Permanente Northern California members. The study population included adults 21 years
and older with no evidence of prior diabetes with an HbA1c reading 6.5% or greater between
January 1, 2014 and December 31, 2015. Individuals were classified as undiagnosed with Type 2
diabetes if they had no associated ICD-9/10 diagnostic code for diabetes and did not have
diabetes added to their record in the year following the first elevated HbA1c value.
Of the 18,356 patients that had an elevated HbA1c and identified as meeting the level for type 2
diabetes, 12,804 (69.8%) were clinically diagnosed with type 2 diabetes and 5,552 (30.2%) were
not clinically diagnosed within the one year. Of those 5,552 undiagnosed, 26% were adults aged
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70 and older, Asian, Latino and Black comprised 57.1% and 92.2% had HbA1c levels between
6.5% and 6.9%. Most notably, among those not clinically diagnosed with type 2 diabetes, 65.2%
had a previous diagnosis of prediabetes, 30.8% were identified as overweight and 53.7% were
identified as obese. These are well known risk factors for type 2 diabetes and along with an
elevated HbA1c should have provided enough evidence to prompt a clinical diagnosis of type 2
diabetes, yet only 40.5% of undiagnosed individuals had follow-up testing and of those only
12.1% had a confirmatory HbA1c value (Gopalan et al., 2018). The low percentage of follow-up
testing could be a factor in lack of awareness as no diagnosis could be made based on a
confirmatory HbA1c value. Consistent with PCP behaviors in the study done by Tseng et al.
(2019), the percentage of clinically undiagnosed individuals can likely be attributed to provider’s
misinterpretation of diagnostic guidelines and knowledge of risk factors such as overweight and
obesity, previous diagnosis of prediabetes and certain race/ethnicities. Ensuring follow-up on
individuals that present with multiple risk factors and an elevated HbA1c will enable a timelier
diagnosis and may help to prevent the development of type 2 diabetes and decrease the risk of its
associated diseases.
D. Gap in the Literature
While there is literature that examines the physician’s knowledge of risk factors
prompting screening, knowledge of the prediabetic ranges for bloodwork laboratory values, and
recommended treatment options for those diagnosed as prediabetic, there is a gap in
understanding the role and current knowledge within the dental community. The new legislation
in Connecticut presents a unique time to assess awareness and utilization, and, determine if
improved messaging is required to the dental care community from professional societies and the
Department of Public Health.
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Prior research by Estrich, Araujo and Lipman (2019) regarding prediabetes and diabetes
screening in dental care settings, estimated the number of people who are likely unaware of their
prediabetes risk status. Using NHANES data from 2013 to 2014 and 2015 to 2016 that included
10,472 adults, associations among prediabetes and diabetes risk factors, usage of health care and
HbA1c levels were analyzed (Estrich, Araujo, & Lipman, 2019). The impact of this study on an
important public health issue is evident in the findings estimating that 22.36 million adults could
be made aware of their risk for prediabetes or diabetes by providing this assessment in a dental
setting because 7.73% of adults had visited the dentist in the last year but not a medical provider
(Estrich, Araujo, & Lipman, 2019). The results of this study show that screening in a dental
setting would have the highest odds of identifying undiagnosed individuals who are at greater
risk due to their race, weight status and age (Estrich, Araujo, & Lipman, 2019). These results
support an additional opportunity to augment the primary care doctor-patient relationship as it
introduces a novel way to increase awareness among this population. Through increased
screening, identification and diagnosis in the early stages becomes possible. Only through
awareness is choice an option. By promoting prediabetes screenings in dental care settings, a
collaboration can be formed between the medical provider, dental care provider and patient
which may likely lead to improved health outcomes.
Prediabetes is a preventable chronic disease and the early diagnosis and treatment should
be a focus of healthcare professionals as it is well documented in the evidence that it can be
reversed. By understanding if the same gaps in knowledge are present among dental providers
and addressing these areas for improvement, there is a great opportunity to increase awareness in
this population with the ultimate goal of reducing the prevalence of prediabetes and the incidence
of type 2 diabetes.
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E. Theoretical Framework
The theoretical framework for this project is based on the concepts of planned behavior
and reasoned action. One fundamental aspect of these theories is that knowledge, attitudes and
beliefs are strong predictors of intentions and intention predicts behaviors (Greenberg, Glick,
Frantsve-Hawley, & Kantor, 2010). This research project sought to understand the level of
knowledge of the new law in Connecticut, the billing code associated with in-office point of
service testing as well as perceptions of patients and prediabetes. This data could be used as a
starting point to develop a plan to increase adoption of administering the in-office point-ofservice testing used to measure HbA1c levels and to increase identifying patients at risk of
prediabetes. Along with other important health screenings currently performed by dentists such
as those for smoking-cessation and oral cancer, screening for prediabetes could present an
opportunity not only for identification but also as a channel to disseminate treatment information.
There is emerging evidence that periodontitis is associated with higher levels of HbA1c, fasting
glucose and the prevalence of prediabetes which contributes additional reasoning as to why it is
important to diagnose early in those individuals that are at risk (Preshaw & Bissett, 2019). If
these conditions can be identified and treated in individuals that are at risk, the benefits far
outweigh any inconveniences this additional screening may cause
II. Specific Aims
A. Research Objectives
To examine the current level of awareness among dentists of the following: 1.) the law
passed in Connecticut in July 2019 (Appendix A) allowing dentists to test blood sugar in office,
2.) the current billing code D0411 (Appendix B) related to HbA1c in-office point-of service
testing in dental office and 3.) the 7 Question Prediabetes Risk Test (Appendix C) provided by
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the American Diabetes Association (ADA) and the Centers for Disease Control and Prevention
(CDC). By assessing this knowledge base, we can begin to understand if there is an opportunity
to increase awareness within this community. The dental community may play an important role
in conjunction with medical providers towards empowering this population identified as
prediabetic to choose lifestyle modifications that have been proven to reverse this condition to a
state of normal glucose tolerance, thereby not developing type 2 diabetes and other costly life
altering conditions including periodontitis. In a study by Greenberg et al. (2010) regarding
dentists’ attitudes toward chairside screening, the authors discuss the factors that are important in
disease prevention. These factors can be applied to this research project in the following manner.
An integrated healthcare approach such as the collaboration between the dental community and
the medical community. A disease with modifiable risk factors such as prediabetes has been
proven with lifestyle modifications such as loss of weight and exercise to either reverse the
diagnosis or slow the progression of developing type 2 diabetes. A simple safe screening tool
such as the Prediabetes Risk Test and the in-office point of service HbA1c test to identify those
at greatest risk. The final factor of effective disease prevention is having the population that
would benefit from this screening and identification process. Based on the increasing prevalence
of both prediabetes and type 2 diabetes along with their associated diseases in the United States,
there is an immense benefit for improving health outcomes for this population (Greenberg,
Glick, Frantsve-Hawley, & Kantor, 2010).
B. Hypothesis
It is hypothesized that a greater level of awareness of the new law, the billing code and
the Prediabetes Risk Test will be associated with a greater likelihood of administering the inoffice point-of-service HbA1c test to patients. In order to assess this opportunity within the
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dental community, an exploratory research study was conducted to inform an understanding
between the knowledge of billing codes, knowledge of a new law passed in Connecticut effective
July 1, 2019, knowledge of the 7 Question Prediabetes Risk Test and the likelihood of
administering an in-office blood sugar test among their patient population. The awareness levels
will serve as the independent variables and the likelihood to administer the in-office point-ofservice HbA1c test as the law is currently written and the likelihood to offer the test if a dental
hygienist could perform the test will function as the dependent variables.
III. Methods and Materials
A. Study Design
The anonymous seventeen question cross-sectional online survey was developed utilizing
feedback from an advisory committee as well as suggestions from the local dental community.
The questions were phrased to reduce any biases pertaining to knowledge or perceptions. The
survey was distributed to licensed practicing dentists utilizing e-newsletters and social media
platforms of major dental organizations based in Connecticut. These organizations include the
Connecticut State Dental Association, Connecticut Oral Health Initiative and the Hartford Dental
Society. The membership of these organizations determined the number of potential survey
participants. The target population for survey distribution was licensed practicing dentists in the
state of Connecticut. This target population was chosen because the law is specifically written to
allow “a dentist licensed under chapter 379 of the general statutes may, during an office visit or
prior to a procedure and with a patient’s consent, administer an in-office point-of-service test to
the patient to measure the patient’s HbA1c percentage utilizing a finger-stick measurement tool”
(An Act Concerning Dental Practitioners of 2019).
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B. Survey Distribution
This anonymous survey was distributed utilizing the Connecticut State Dental
Association (CSDA), Connecticut Oral Health Initiative (COHI) and Hartford Dental Society
member email lists and their associated social media platforms. The recruitment flyer (Appendix
D) which includes a link and a QR code to access the anonymous survey was distributed by the
Connecticut State Dental Association (CSDA) using e-newsletters sent to their members on
February 21, 2020 and March 6, 2020 and posted on their Facebook page on February 27, 2020
which is followed by 600 people. The recruitment flyer was also included in the Connecticut
Oral Health Initiative e-newsletters sent to their members in February and March and posted on
their Facebook page on March 10, 2020 which is followed by 288 people. Additional methods of
distribution included emails sent to each contact for the twenty-two local component societies
within Connecticut that are an important part of organized dentistry in the state and serve the
needs of member dentists at the local level. (Component Societies, 2020). Additional emails
were sent to a random sample of eight individual practices in Connecticut using a list of licensed
practicing dentists provided by the Department of Public Health. This approach to data collection
uses the method of convenience sampling and is useful for this project to gain an understanding
within the dental community of Connecticut. This is a non-probability sample because the survey
was only distributed to those members that receive the e-newsletters from CSDA and COHI or
subscribe to their Facebook pages, are a member of the component societies or are currently
licensed in the state of Connecticut.
C. Survey Instrument
Knowledge within the dental community was measured using a descriptive crosssectional anonymous survey developed in Qualtrics. The cross-sectional anonymous survey is
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based on an instrument used by Tseng et al. (2019) in a study assessing knowledge, practices and
perception of prediabetes among primary care physicians. The questions in our survey were
modified and tailored by myself and my advisory committee to gain an understanding of the
knowledge within the dental community. An introduction is included describing the purpose of
the survey and that completion of the survey is indicative of their consent to participate. The
information sheet also included contact information for study personnel.
The survey collected quantitative data to evaluate the following: 1) perceptions regarding
prediabetes, 2) knowledge of ADA billing codes that correspond to in-office monitoring of
patient’s blood sugar, 3) knowledge of the “Act Concerning Dental Practitioners”, and 4)
knowledge of 7 Question Prediabetes Risk Test.
The first section of the survey included questions related to the participant’s awareness of
the 7 Question Prediabetes Risk Test, their willingness to incorporate this test into their patient
information forms, the current data collected on their patient information forms, their awareness
of the law passed in Connecticut in July 2019, “An Act Concerning Dental Practitioners” and
their knowledge of the reimbursable quality of CDT Code D0411 (HbA1c in office point-ofservice testing in dental office). The other questions in this section pertain to the likelihood of
administering the in-office point-of-service test. The language of the current law states that the
test can only be performed by a licensed practicing dentist. These questions ask if the participant
is currently administering the in-office point-of-service test. If the participant answered no to this
question, to examine the feasibility of increasing the number of tests administered in the dental
office, the question was asked how likely they would be to offer the test if it could be performed
by a dental hygienist. The last two questions in this section pertain to the likelihood of offering
the in-office point-of-service test if it is not reimbursable and how likely a patient would be to
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pay out of pocket if this test is not reimbursable. These questions attempt to examine the
feasibility of offering the test if it not reimbursable.
In the final section of the survey, the participants are asked questions that will provide
demographic information pertaining to their gender, number of years practicing dentistry,
specialty, type of practice, and insurance status of patients that can be compared to the total
sampling frame of licensed practicing dentists in Connecticut. The data provided by these
answers are reported using descriptive statistics. These findings may potentially be utilized in
further analyses to understand the differences based on employment status.
D. Variables and Data Analysis
IBM SPSS Statistics 26 software was utilized to analyze the collected data. Descriptive statistics
were calculated to examine the distribution of scores on each of the survey questions.
Frequencies and chi-square tests were run to evaluate associations between the independent and
dependent variables.
In the first section of the survey, a 5-point Likert scale (strongly agree to strongly
disagree) was used to evaluate the perceived relationship between prediabetes and periodontal
disease, perceptions of the importance to collaborate with the medical community to prevent
disease, perceptions of the importance of screening for prediabetes, perceptions of the
importance of informing patients of prediabetes, as well as perceptions by the dental community
of patient behaviors. The answers to these questions were dichotomized by combining agree and
strongly agree versus neutral, disagree and strongly disagree (Tseng et al., 2019).
The answers to questions related to perceptions of prediabetes, awareness of the new law,
awareness of the billing code, awareness of the Prediabetes Risk Test and the likelihood of
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administering the test were compared for associations. This analysis informs the findings related
to the hypotheses.
E. Confidentiality
The UConn Institutional Review Board (IRB) approved this study on February 13, 2020
under Exemption Category 2 - Research that only includes interactions involving educational
tests (cognitive, diagnostic, aptitude, achievement), survey procedures, interview procedures or
observations of public behavior (including visual or auditory recording). There is minimal risk
posed to the subjects due to the anonymous nature of the survey. There is minimal risk to breach
of confidentiality because it is an anonymous survey. The Principal Investigator, CoInvestigators, and Study Coordinator had access only to the data. All key study personnel
completed the Collaborative Institutional Training Initiative (CITI).
IV. Results
A. Response Rates
As shown in Figure 1, approximately 6,269 individuals in the dental community received
an e-newsletter from CSDA (3769) and COHI (2500). On February 21, 2020, CSDA sent their enewsletter to 1,892 dental professional members and it was opened by 631 (33.4%). Of those 631
who opened the e-newsletter, 6 (0.95%) individuals opened the anonymous survey link. On
March 6, 2020, CSDA sent their e-newsletter to 1,877 dental professional members and it was
opened was by 748 (39.9%). Of those 748 who opened the newsletter, 3 (0.4%) individuals
opened the anonymous survey link. On March 4, 2020, COHI sent their e-newsletter to
approximately 2,500 dental professionals and was opened by 508 (20.3%). Among those 508
who opened the COHI e-newsletter, 4 (0.79%) individuals opened the anonymous survey link.
Based on the total number of e-newsletters sent out in February and March of 6269 with an
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average open rate of 31.2% it can be estimated that 1956 e-newsletters would be opened. Using
0.71% as the average standard open rate for the anonymous survey, it can be estimated that the
anonymous survey link would receive approximately 14 clicks. With additional distribution
through the Hartford Dental Society member email lists and postings on social media platforms,
we received 23 completed surveys in the time period from February 21, 2020 through March 20,
2020.
Survey Distribution and Response Rates
"REQUEST FOR SURVEY
PARTICIPANTS IN E-NEWSLETTERS"
n = 6269
CSDA n = 1892 (2/21/2020)
CSDA n = 1877 (3/6/2020)
COHI n = 2500 (3/4/2020)

NUMBER OPENED AND OPEN RATE
CSDA n = 631 (33.4%) (2/21/2020)
CSDA n = 748 (39.9%) (3/6/2020)
COHI n = 508 (20.3%) (3/4/2020)

UNIQUE CLICKS ON ANONYMOUS
SURVEY
CSDA n = 6 (0.95%) (2/21/2020)
CSDA n = 3 (0.4%) (3/6/2020)
COHI n = 4 (0.79%) (3/4/2020)

23 COMPLETED SURVEYS
FEBRUARY 21 - MARCH 20

Figure 1 Distribution and Response Rates for anonymous survey
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B. Characteristics of Study Sample
Table 1 includes the demographics of the study sample. Among those who completed the
survey, 69.6 percent were male; 66.7 percent listed their specialty as General Dentistry; 69.6
percent had practiced more than 20 years; 95.6 percent were in a private or group practice and on
average 62.1 percent of their patients had employer-based plans for insurance. Compared with
the target population for the state of Connecticut, the pilot study sample had similar
demographics in gender, those practicing less than 20 years and those practicing General
Dentistry, Oral and Maxillofacial Surgery and Oral and Dentofacial Orthopedics. Type of
practice and insurance breakdown was not available for the total population of licensed
practicing dentists in Connecticut.
C. Role of Dentists in Screening
Figure 2 shows the distribution of responses for the five-point Likert scale questions.
Over 90 percent of survey respondents indicated that they “agreed” (“strongly agree” or
“somewhat agree”) that it is important to collaborate with primary care providers to prevent
disease. Over 85 percent “agreed” that it is both important to screen patients identified at risk for
prediabetes as well as important for the dental community to inform patients of a prediabetic
condition. Over 20 percent of respondents “did not agree” (“somewhat disagree” or “strongly
disagree”) and more than 30 percent “neither agreed nor disagreed” that patients would make
lifestyle changes if given informational material on prediabetes.
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How Strongly Do You Agree or Disagree
n = 23
25
91.3%

86.9%

86.9%

20

15
47.8%

52.2%

10
5
0
Important to collaborate Important to screen patients Important to inform patients
with PCP to prevent disease
identified at risk
of prediabetic condition
Strongly agree or somewhat agree

Patients make lifestyle
changes if given
informational material

Neither agree or disagree or Somewhat disagree or Strongly disagree

Figure 2 – Distribution of responses to Question 1 using five-point Likert scale

Awareness of 7-Question Prediabetes Risk Test and Willingness to Adopt. As shown
in Figure 3, 78 percent of respondents answered “no” or “not sure” regarding their awareness of
this test. The following question asked how likely you would be to incorporate the Prediabetes
Risk Test into your patient information forms. Nearly three quarters of the respondents answered
that they would “possibly”, “probably” and “definitely” incorporate the risk test.
Not sure
13%

Yes
22%
When asked how likely
they would be to
incorporate the
Prediabetes Risk Test into
their patient information
forms, nearly three
quarters of respondents
answered "definitely" or
"probably" or
"possibly"

78% of respondents
answered "no" or "not
sure" regarding their
awareness of the
Prediabetes Risk Test.

No
65%
Figure 3 – Responses to Question 2 “Are you aware of the 7- Question Prediabetes Risk Test”
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Awareness of New Law and Willingness to Adopt HbA1c Testing. As shown in
Figure 4, only 22 percent of respondents are aware of “An Act Concerning Dental Practitioners”.
96 percent of respondents are not currently administering the test. Among those not currently
testing, nearly three quarters responded that they would “possibly”, “probably” or “definitely”
administer the test. While this total percentage remains the same when asked in question 8 of the
likelihood to offer the test if it could be administered by a dental hygienist under their
supervision, there was an increase in those answering “definitely” or “probably” from 27 percent
to 50 percent.

AWARE OF "AN ACT CONCERNING DENTAL PRACTITIONERS"

96% of respondents
are currently not
administering the test

Not sure
17%

Yes
22%

When asked how
likely to administer the
test, nearly three
quarters of respondents
answered "definitely"
or "probably" or
"possibly"

When asked how likely
to offer the test if a
dental hygienist could
perform under
supervision, 50% of
respondents answered
"definitely" or
"probably" compared to
27.2% when just the
licensed dentist could
perform.

No
61%
Figure 4 – Responses to Question 5 “Are you aware of “An Act Concerning Dental Practitioners”

V. Discussion
This pilot study is the first known attempt to assess the awareness and utilization of Sec.
11. Public Act 19-72 “An Act Concerning Dental Practitioners” effective July 1, 2019 in
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Connecticut. This law was proposed and passed to remove barriers to screening an at-risk
population primarily for early detection of disease. This legislation also allows dentists to play an
important role in collaborating with the medical community to impact the overall health of the
patient.
A. Willingness to Adopt Testing and Risk Assessment.
Although our study yielded a small sample size, our results are encouraging regarding the
willingness to adopt this testing. For example, the vast majority (91.3%) “strongly agreed” or
“somewhat agreed” that is important for the dental community to collaborate with primary care
providers to prevent disease. Additionally, the majority (86.9%) also “strongly agreed” or
“somewhat agreed” that it is important to screen patients identified at risk for prediabetes as well
as to inform patients of a prediabetic condition. There was a moderate difference in the numbers
that “strongly agreed” to inform (65.2%) compared to screen (47.8%). These results suggest that
participants may have defined screening as the HbA1c test and not the risk test. Clarification on
this question is recommended for future surveys. While these results imply that the majority of
respondents believes these are important, the current utilization of screening either with the
Prediabetes Risk Test and/or the HbA1c in-office point of service test is near nonexistent with
only one respondent currently administering the test. One reason for this may lie in the fact that
only 47.8% of respondents answered “strongly agree” or “somewhat agree” that patients would
make lifestyle changes if given informational material on prediabetes compared to the other
questions related to perceptions.
An opportunity exists to include the Prediabetes Risk Test as a standard routine patient
form as the majority (73.8%) answered they would be likely to incorporate the Prediabetes Risk
Test into their patient forms even though the majority (65.2%) were not aware of this screening
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tool. This single screening tool could be the simplest and easiest option to implement and have
the greatest impact on raising awareness of prediabetes risk among this patient population and
allow a choice to be made regarding treatment options.
The following results in conjunction with perceptions of importance to screen patients,
inform patients and collaborate with medical providers imply that testing patients chairside has
the potential to be implemented on a larger scale. The majority (72.7%) are “definitely”,
“probably” or “possibly” likely to administer the in-office point-of-service test to patients and
the same is true of offering the test if it could be administered by a dental hygienist under the
dentist’s supervision regardless of only 21.7% having awareness of the law.
Additional factors also impact the decision to administer the HbA1c test such as the
availability and cost of the equipment needed to run the tests, CLIA waivers necessary to run the
tests in the office, insurance coverage and out of pocket costs for the patients. As of January 1,
2018, Code D0411 “HbA1c in-office point of service testing” has been effective as a billing code
for this procedure pertinent to in-office monitoring of patient blood glucose levels yet only
34.8% were aware if this code is reimbursable.
B. Cost Considerations
Of concern is that 60.8% responded that patients would “probably not” or “definitely not”
pay for the HbA1c test if it is not reimbursable. The current cost of twenty CLIA waived
A1CNow test kits is approximately $182.00, less than $10/test (Appendix E). There is the
possibility that the HbA1c test could follow a similar model to that of fluoride varnish in adults,
which is typically not covered by insurance. In this scenario, the patient pays out of pocket if
financially able and they decide it is an important procedure to maintain good oral health. Based
on the approximate cost per test of less than ten dollars, the test could be offered to the patient
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for a fee determined by the dentist and based on income level. The cost of the test to the patient
will likely be significantly less than the cost of treating type 2 diabetes, assuming treatment and
change of behaviors follows. While cost may still present a barrier due to a patient’s income
level, partnerships could be developed with organizations to cover the cost of the test for these
individuals. Additional factors such as time allotted to each patient visit and the availability of
the dentist also affect the rates of administering the tests. One suggestion that may address time
constraints of dentists is to amend the law to include dental hygienists as professionals allowed
to administer the blood test. Not only is this in line with the scope of practice of a dental
hygienist but could increase the capacity to test at-risk patients.
C. Limitations
There may be other factors outside the scope of this study that would limit or advance the
likelihood of administering the in-office point-of-service HbA1c test. Another limitation of this
study which might affects internal validity is non-response bias, which is common in survey
research. An average response rate to an online survey is 30% (Lindemann, 2020). The response
rate for this small pilot study did not achieve this response rate, therefore, we have not drawn
major inferences. An additional limitation may exist in the delivery method for our survey. The
link to the anonymous survey was included as the last item in the e-newsletter. Therefore, a
limited amount of time to spend online as well as a limited attention span may have impacted our
results. In our small sample, the majority practiced 20 years or more and practiced in a private or
group setting. The demographics of our study sample pose a limitation as they are not
representative of the group of licensed practicing dentists in Connecticut. There is also the
potential for social desirability bias (Bhattacherjee, 2012). Dental providers responding to this
survey may give answers that portray themselves in a more positive light rather than what they
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truly believe. Although we cannot evaluate the responses in this manner due to the online nature
of the survey, the questions were constructed to minimize biased responses. For example, we
chose to use the word “aware” versus “knowledge” when asking about the law to minimize the
perception of the question feeling like a challenge to the participant.
VI. Conclusions and Recommendations
This pilot study provides early insight into the need to promote the new legislation and
promising indications about willingness to adopt testing. The results have informed a greater
understanding of the important role the dental community has in conjunction with the medical
community to increase screening and testing of the at-risk population as a tool in the primary
prevention of prediabetes. The results of this study have also informed an understanding of the
awareness among the dental community of a new law passed in Connecticut in July 2019
regarding the ability of dental providers to administer testing of blood sugar. Further research is
needed to examine these results in a larger sample.
A possible venue to increase the sample size is to administer this survey at the annual
meeting for the Connecticut State Dental Association to present the initial findings and recruit
additional participants. The average survey response rate for an in-person survey is 57%
(Lindemann, 2020). Therefore, a potentially large number of surveys that may be representative
of dentists in Connecticut could be secured by recruiting survey participants at this annual
meeting. The next highest average response rate (50%) is to mailed surveys (Lindemann, 2020).
Therefore, an additional recommendation would be to secure funding to perform a mailing of the
survey to all of the licensed practicing dentists in Connecticut.
Future studies examining awareness and factors associated with implementation of
testing in the dental setting may also be structured as in-depth interviews with a representative
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sample of licensed practicing dentists and dental hygienists. To augment these results, additional
interviews and research could be performed with patients identified as at-risk to examine their
understanding of prediabetes, HbA1c measures and the in-office point-of-service blood test. One
final suggestion for future research is to examine similar laws and current utilization of the
HbA1c blood test in the dental setting in other states. The importance of identifying potential
solutions that may have a positive impact on the growing epidemic of prediabetes is critical and
needs to be further explored. By encouraging this practice among the dental community, there is
an opportunity to identify, inform and educate those at risk which offers this at-risk population a
life-saving choice of better health.
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TABLE 1
Demographic characteristics of pilot study sample (n=23)
Demographic Characteristics

Pilot Study Sample
No. (%)

Total Target Population
No. (%)
N = 2449

Male

16 (69.6)

1581 (64.6)

Female

6 (26.1)

796 (32.5)

Prefer not to say

1 (4.3)

72 (2.9)

Gender

Type of practice
Private or group practice
Practice affiliated with hospital or large health

22 (95.6)

Information not available

1 (4.4)

entity

Years in Practice
< 20 years

7 (30.4)

697 (28.5)

>20 years

16 (69.6)

554 (22.6)

Not listed

1198 (48.9)

Specialty (could select more than one)
12 specialties were included in the survey
question based on those recognized by the
National Commission on Recognition of Dental
Specialties and Certifying Boards.
5 specialties received responses and are listed
below:
General Dentistry

16 (66.7)

1787 (73)

Endodontics

2 (8.3)

69 (2.8)

Oral and Maxillofacial Surgery

1 (4.2)

115 (4.7)

Oral and Dentofacial Orthopedics

1 (4.2)

145 (5.9)

Periodontics

4 (16.7)

87 (3.6)

Insurance breakdown of patients avg.
Employer-based plans

62.1%

Medicaid or other state-based program

6.2%

Self-pay

29.8%

No charge/Charity

1.9%

Information not available
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APPENDIX A: Public Act No. 19-72 “AN ACT CONCERNING DENTAL
PRACTITIONERS”

Sec. 11. (NEW) (Effective July 1, 2019) (a) As used in this section:
(1) "Point-of-service test" means diagnostic testing performed at the site where patients will
receive care or treatment; and
(2) "HbA1c percentage" means the proportion of hemoglobin to which glucose is attached
and measures the average circulating blood glucose level over the previous two to three-month
period.
(b) A dentist licensed under chapter 379 of the general statutes may, during an office visit or
prior to a procedure and with a patient's consent, administer an in-office point-of-service test to
the patient to measure the patient's HbA1c percentage utilizing a finger-stick measurement tool if
such patient is at an increased risk of diabetes and does not have a previous diagnosis of diabetes.
A dentist who does not administer such test pursuant to this section shall not be deemed to have
violated the standard of care for a dentist. The Commissioner of Public Health may adopt
regulations in accordance with the provisions of chapter 54 of the general statutes to carry out the
provisions of this section.
Approved July 8, 2019
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APPENDIX B: Code D0411
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APPENDIX C: Prediabetes Risk Test
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APPENDIX D: Recruitment Flyer

RESEARCH STUDIES SEEKING PARTICIPANTS
Recruiting Licensed Practicing Dental Providers in Connecticut to participate in an
anonymous survey

Examining Opportunity in the Dental Community to Identify Prediabetes
We are from UConn Health doing research pertaining to new legislation passed in
Connecticut allowing dental providers to administer an in-office point-of-service test to
measure a patient's hemoglobin A1c (HbA1c) percentage. This finger stick test
measures average blood sugar levels over the past 3 months.
This survey is anonymous, and we will not collect any identifiable information (name,
age, practice name, address).
This study will help us learn about:
o
o
o

Awareness of the new legislation in Connecticut
Current utilization of the in-office point-of-service HbA1c test
Perceptions of screening patients for prediabetes in office

This is a brief survey (17 questions) and should take approximately 5-10 minutes to
complete. Risks are minimized by anonymized responses and there are no direct
benefits associated with this research.
If you would like more information, you can contact Helen Swede at (860) 679-5568 or
via email at swede@uchc.edu or Kirsten Carew at (860) 777-5100 or via email
at carew@uchc.edu.
QR Code will link to anonymous survey:
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APPENDIX E: A1C test kit example
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